COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
about
E-type prostanoid receptor 4 (EP4) in disease and therapyIL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryProgrammed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaSTAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Elucidating the role of interleukin-17F in cutaneous T-cell lymphomaMalignant inflammation in cutaneous T-cell lymphoma-a hostile takeovermiRNA in mycosis fungoides and skin inflammation.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaVascular endothelial growth factor receptor-3 expression in mycosis fungoides.COX-2 is a novel target in therapy of mycosis fungoides.Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.
P2860
Q26851156-36D239D5-A0CB-47C3-9C47-262C38755BAAQ33728396-513F83C5-DCC0-4E4E-A2EB-658275C008A3Q34096843-C16837D4-2EA0-4B7E-8386-E52805E7678BQ34154516-67FB9ED9-2413-4381-AF65-E867BA66E284Q35987358-E457339E-0E18-457D-905D-BEBFBFCA9EC6Q36020985-07E47257-967F-4A2E-BF8F-A62F2BDC6C74Q36363166-2292A289-862F-4663-999B-7CCC46D8E333Q36675064-7F162C55-7FEA-46CE-BDD3-E7FD53B920A9Q37075919-671A0553-0C1B-4481-831C-42482DC6F954Q37139517-C107575F-83B9-44C5-8D96-B58BCCCB7F0EQ37216178-9B3288BB-F723-42F3-B771-E0D5562426B0Q37723390-F627E7F2-669C-4087-9917-FF616AB45AC0Q38150868-41249AAA-8AF4-41CB-BEEF-C7CE10C0F4C7Q38846167-FFE9DD38-8CB7-4A03-822C-981C7FFEA704Q39285766-5068B5E1-04C2-4C71-9673-3C68ABD15F70Q42873280-65E828F6-EB7A-4ED9-82D2-B5E7A35E628CQ44374191-F9EFBAA5-D009-4597-AC72-D167E4F7E8B2Q47166524-6A1DFDCF-FF65-4B68-9A39-08C519D03D85
P2860
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
COX-2-dependent PGE
@nl
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
@en
type
label
COX-2-dependent PGE
@nl
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
@en
prefLabel
COX-2-dependent PGE
@nl
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
@en
P2093
P2860
P50
P356
P1433
P1476
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF)
@en
P2093
B Lauenborg
C S Kauczok
E Ralfkiaer
J C Becker
K W Eriksen
P2860
P2888
P304
P356
10.1038/LEU.2010.66
P577
2010-04-29T00:00:00Z